Home LiteratureArticle Details
PMID: 17487239 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in mice.

Canadian journal of physiology and pharmacology ·Vol. 84 ·No. 12 ·2006-12-00 ·Pages 1301-12

Skinn AC, Vergnolle N, Zamuner SR, Wallace JL, Cellars L, MacNaughton WK, Sherman PM

Abstract

Attaching-effacing bacteria are major causes of infectious diarrhea in humans worldwide. Citrobacter rodentium is an attaching-effacing enteric pathogen that causes transmissible murine colonic mucosal hyperplasia. We characterized colonic inflammation and ion transport at 3, 7, 10, 30, and 60 d after infection of C57Bl/6 mice with C. rodentium. Macroscopic damage score was significantly increased 7 and 10 d after infection. Colonic wall thickness was increased at 7, 10, 30, and 60 d. Myeloperoxidase (MPO) activity was significantly increased at 3, 7, and 10 d and returned to control levels by days 30 and 60. The expressions of inducible nitric oxide synthase and cyclooxygenase-2 were increased by C. rodentium infection. Significant reductions in the epithelial secretory response to carbachol, but not to electrical field stimulation or forskolin, were observed at 3 and 10 d of infection. Translocation of enteric bacteria into the mesenteric lymph nodes was observed 10 d following infection. There was no difference in response to infection between animals deficient in inducible nitric oxide synthase and wild-type controls. The COX-2 inhibitor rofecoxib caused decreased wall thickness and MPO activity at day 10. However, COX-2 inhibition did not alter infection-induced changes in ion transport. Citrobacter rodentium infection causes colonic inflammation, mucosal hyperplasia, and nitric-oxide-independent epithelial dysfunction in association with increased permeability to luminal bacteria.

MeSH Terms
Animals Bacterial Translocation Carbachol/pharmacology Cell Membrane Permeability Cholinergic Agonists/pharmacology Citrobacter rodentium Colitis/metabolism,microbiology,pathology,physiopathology Colon/drug effects,metabolism,microbiology,pathology,physiopathology Cyclooxygenase 2/metabolism Cyclooxygenase 2 Inhibitors/pharmacology Enterobacteriaceae Infections/complications,metabolism,microbiology,pathology,physiopathology Hyperplasia Intestinal Mucosa/drug effects,metabolism,microbiology,physiopathology Intestinal Secretions/metabolism Ion Transport Lactones/pharmacology Lymph Nodes/microbiology Mice Mice, Inbred C57BL Mice, Knockout Nitric Oxide Synthase Type II/deficiency,genetics,metabolism Peroxidase/metabolism Sulfones/pharmacology Time Factors
Chemicals
Cholinergic Agonists Cyclooxygenase 2 Inhibitors Lactones Sulfones rofecoxib Carbachol Peroxidase Nitric Oxide Synthase Type II Nos2 protein, mouse Ptgs2 protein, mouse Cyclooxygenase 2
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Skinn Andrew C
Mucosal Inflammation Research Group and Department of Physiology and Biophysics, University of Calgary, 3330 Hospital Dr NW, Calgary, AB T2N 4N1, Canada.
Vergnolle Nathalie
Zamuner Stella R
Wallace John L
Cellars Laurie
MacNaughton Wallace K
Sherman Philip M
Article Info
Journal
Canadian journal of physiology and pharmacology
Abbr.
Can J Physiol Pharmacol
ISSN
0008-4212
Published
2006-12-00
Pages
1301-12
Language
English
Region
Canada
NLM ID
0372712
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com